Promotes tumor progression, proliferation, and invasion. Inhibits apoptosis and induces chemoresistance.In C2C12 cell models, downregulated miR221/222 is observed which is associated with cachectic and sarcopenic condition vis MyoD-myomiRs regulatory pathway. The gene discussed is MYOD1; the disease is neoplasm.